From: Increased sialylation of site specific O-glycoforms of hemopexin in liver disease
 | All (n = 46) | Fibrosis (n = 22) | Cirrhosis (n = 24) | |||
---|---|---|---|---|---|---|
rs | p value | rs | p value | rs | p value | |
Age | −0.034 | 0.832 | 0.160 | 0.489 | 0.017 | 0.945 |
Bilirubin (mg/dL) | 0.409 | 0.008* | 0.088 | 0.705 | 0.393 | 0.086 |
Creatinine (mg/dL) | −0.166 | 0.270 | 0.129 | 0.568 | −0.363 | 0.081 |
INR | 0.390 | 0.012* | 0.039 | 0.866 | 0.006 | 0.979 |
MELD | 0.279 | 0.061 | 0.215 | 0.338 | 0.134 | 0.534 |
AFP (ng/mL) | 0.578 | <0.001* | 0.429 | 0.052 | 0.439 | 0.053 |
Albumin (g/dL) | −0.436 | 0.004* | −0.040 | 0.862 | −0.511 | 0.021* |
Alk. phosphastase (U/L) | 0.195 | 0.193 | 0.116 | 0.608 | 0.185 | 0.387 |
ALT (U/L) | 0.337 | 0.031* | −0.163 | 0.480 | 0.346 | 0.135 |
AST (U/L) | 0.520 | 0.001* | −0.087 | 0.709 | 0.747 | 0.001* |
Platelet (109/L) | −0.564 | <0.001* | −0.462 | 0.035* | −0.358 | 0.121 |
FIB-4 | 0.612 | <0.001* | 0.366 | 0.103 | 0.574 | 0.008* |
APRI | 0.562 | <0.001* | 0.158 | 0.493 | 0.589 | 0.006* |